approved glp 1 agonists GLP-1: Genetic Variants Related to GLP-1 RA Medications Visible Alpha GLP-1 drug monitor

2 Based on available evidence, there have been no cases of MTC in humans linked to GLP-1 RAs

Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes

Drugs like ACE inhibitors, ARBs, or NSAIDs can increase kidney stress when combined with dehydration

Existing CVOT subgroup analyses already provide a basis for this, consistently showing greater benefits in patients with established ASCVD compared to those in a primary prevention setting [51]

Specific warnings include the risk of aspiration for patients, the need for patients to inform their anaesthetist they are taking these medications, and for anaesthetists to consider the heightened risk of aspiration and to manage such patients accordingly

Tate M, Robinson E, Green BD, et al